Ensign Peak Advisors, Inc

Holdings History for Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

Symbol: VIR on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0%	$3,204,529	531,431	-23,550	-4.2%	$6.03	Q4 2025
30 Sep 2025	0.01%	-0%	$3,168,942	554,981	-28,000	-4.8%	$5.71	Q3 2025
30 Jun 2025	0.01%	+0%	$2,938,224	582,981	+519,107	+813%	$5.04	Q2 2025
31 Mar 2025	0%	0%	$413,904	63,874	0		$6.48	Q1 2025
31 Dec 2024	0%	0%	$468,835	63,874	0		$7.34	Q4 2024
30 Sep 2024	0%	+0%	$478,416	63,874	+13,600	+27%	$7.49	Q3 2024
30 Jun 2024	0%	0%	$447,439	50,274	0		$8.90	Q2 2024
31 Mar 2024	0%	-0%	$509,276	50,274	-2,536	-4.8%	$10.13	Q1 2024
31 Dec 2023	0%	+0%	$531,269	52,810	+22,800	+76%	$10.06	Q4 2023
30 Sep 2023	0%	-0%	$281,194	30,010	-147,691	-83%	$9.37	Q3 2023
30 Jun 2023	0.01%	0%	$4,359,005	177,701	0		$24.53	Q2 2023
31 Mar 2023	0.01%	+0%	$4,135,103	177,701	+63,511	+56%	$23.27	Q1 2023
31 Dec 2022	0.01%	+0%	$2,890,149	114,190	+7,350	+6.9%	$25.31	Q4 2022
30 Sep 2022	0.01%	+0%	$2,060,000	106,840	+38,151	+56%	$19.28	Q3 2022
30 Jun 2022	0%	-0%	$1,749,000	68,689	-44,820	-39%	$25.46	Q2 2022
31 Mar 2022	0.01%	+0%	$2,919,000	113,509	+2,940	+2.7%	$25.72	Q1 2022
31 Dec 2021	0.01%	+0.01%	$4,629,000	110,569	+110,569	NEW	$41.87	Q4 2021
31 Dec 2020		-0%	$0	0	-24,128	-100%	$9.32	Q4 2020
30 Sep 2020	0%	+0%	$829,000	24,128	+18,578	+335%	$34.36	Q3 2020
30 Jun 2020	0%	+0%	$227,000	5,550	+5,550	NEW	$40.90	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.